Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma:a Multicenter Real-World Study

被引：0
|
作者：
Liu, Na [1 ]
Wang, Luqun [2 ]
Liu, Rentong [3 ]
Zhong, Yuping [4 ]
Feng, Xianqi [5 ]
Sun, Zhongliang [6 ]
Li, Jie
Meng, Fanjun [7 ]
Ma, Junjie [8 ]
Yuan, Changyong [9 ]
Li, Hao [10 ]
Wang, Ling [11 ]
Xu, Zhilong [12 ]
Yu, Jie [13 ]
Zhang, Hao [14 ]
Chen Chunyan [15 ]
机构：
[1] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[3] Binzhou Med Coll, Affiliated Hosp, Shandong, Peoples R China
[4] Univ Hlth & Rehabil Sci Qingdao Hosp, Qingdao Municipal Hosp, Qingdao, Peoples R China
[5] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[6] First Peoples Hosp Jining City, Shandong, Peoples R China
[7] Qingdao Univ, Affiliated Hosp, Qiangdao, Peoples R China
[8] Yantai Yuhuangding Hosp, Yantai, Peoples R China
[9] Shandong Univ, Dezhou Peoples Hosp, Qilu Hosp, Dezhou Hosp, Dezhou City, Peoples R China
[10] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[11] Taian Cent Hosp, Tai An, Shandong, Peoples R China
[12] Lanling Cty Peoples Hosp, Iinyi, Peoples R China
[13] Weihai Municipal Hosp, Weihai, Peoples R China
[14] Jining Med Univ, Affiliated Hosp, Jining, Peoples R China
[15] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma
    Rocchi, Serena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Rizzello, Ilaria
    di Giovanni Bezzi, Chiara
    Scalese, Marco
    Dozza, Luca
    Marzocchi, Giulia
    Martello, Marina
    Barila, Gregorio
    Antonioli, Elisabetta
    Staderini, Michela
    Buda, Gabriele
    Petrini, Mario
    Cea, Michele
    Quaresima, Micol
    Furlan, Anna
    Bonalumi, Angela
    Cavo, Michele
    Zamagni, Elena
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 41 - 50
  • [2] Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
    Onda, Yoshiyuki
    Kanda, Junya
    Kaneko, Hitomi
    Shimura, Yuji
    Fuchida, Shin-ichi
    Nakaya, Aya
    Itou, Tomoki
    Yamamura, Ryosuke
    Tanaka, Hirokazu
    Shibayama, Hirohiko
    Shimazu, Yutaka
    Uchiyama, Hitoji
    Yoshihara, Satoshi
    Adachi, Yoko
    Matsuda, Mitsuhiro
    Hanamoto, Hitoshi
    Uoshima, Nobuhiko
    Kosugi, Satoru
    Ohta, Kensuke
    Yagi, Hideo
    Kanakura, Yuzuru
    Matsumura, Itaru
    Hino, Masayuki
    Nomura, Shosaku
    Shimazaki, Chihiro
    Takaori-Kondo, Akifumi
    Kuroda, Junya
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [3] A REAL-WORLD EFFICACY AND SAFETY ANALYSIS OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE (KRD) COMBINATION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Caratozzolo, I.
    Tacchetti, P.
    Zambello, R.
    Pantani, L.
    Antonioli, E.
    Mancuso, K.
    Buda, G.
    Rocchi, S.
    Canepa, L.
    Rizzello, I.
    Gamberi, B.
    Barila, G.
    Testoni, N.
    Marzocchi, G.
    Zamagni, E.
    Cavo, M.
    HAEMATOLOGICA, 2019, 104 : 66 - 66
  • [4] Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Daratumumab-Naive Relapsed Multiple Myeloma: Multicenter Real-World Experience
    Mansour, Razan
    Davis, James A.
    Minchak, Megan
    Atallah, Rawan
    Saif, Md Saiful Islam
    Logan, Emerson
    Tabak, Carine
    Rashid, Aliya
    Dima, Danai
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142
  • [5] Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China
    Fan, Huishou
    Wei, Rongxia
    Feng, Xiangyan
    Zhang, Xin
    Li, Tianlan
    Liu, Lu
    Wang, Hui
    Sun, Lingjie
    Shi, Xue
    Zhao, Hongguo
    Li, Zhao
    Cui, Jingying
    Feng, Xianqi
    Xu, Junqing
    Ma, Junjie
    Qiu, Lugui
    Wang, Wei
    BLOOD, 2024, 144 : 7032 - 7033
  • [6] Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
    Massimiliano Mirabella
    Luca Prosperini
    Matteo Lucchini
    Laura Boffa
    Giovanna Borriello
    Maria Chiara Buscarinu
    Diego Centonze
    Antonio Cortese
    Chiara De Fino
    Laura De Giglio
    Giorgia Elia
    Roberta Fantozzi
    Elisabetta Ferraro
    Ada Francia
    Simona Galgani
    Claudio Gasperini
    Shalom Haggiag
    Doriana Landi
    Girolama Alessandra Marfia
    Enrico Millefiorini
    Fabrizia Monteleone
    Viviana Nociti
    Marco Salvetti
    Eleonora Sgarlata
    Carlo Pozzilli
    CNS Drugs, 2018, 32 : 963 - 970
  • [7] Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
    Mirabella, Massimiliano
    Prosperini, Luca
    Lucchini, Matteo
    Boffa, Laura
    Borriello, Giovanna
    Buscarinu, Maria Chiara
    Centonze, Diego
    Cortese, Antonio
    De Fino, Chiara
    De Giglio, Laura
    Elia, Giorgia
    Fantozzi, Roberta
    Ferraro, Elisabetta
    Francia, Ada
    Galgani, Simona
    Gasperini, Claudio
    Haggiag, Shalom
    Landi, Doriana
    Marfia, Girolama Alessandra
    Millefiorini, Enrico
    Monteleone, Fabrizia
    Nociti, Viviana
    Salvetti, Marco
    Sgarlata, Eleonora
    Pozzilli, Carlo
    CNS DRUGS, 2018, 32 (10) : 963 - 970
  • [8] Carfilzomib-containing combinations as frontline therapy for multiple myeloma: A meta-analysis of 13 trials
    Sheng, Zhixin
    Li, Guifang
    Li, Bin
    Liu, Yanju
    Wang, Lida
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (06) : 601 - 607
  • [9] Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel M.
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew J.
    Sperling, Adam S.
    Anderson Jr, Larry D.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [10] Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis
    Varma, Gaurav
    Fogel, Lindsay
    Gordon, Beth
    Saldarriaga, Mateo Mejia
    Ahn, Jaeil
    Aleman, Adolfo
    Caro, Jessica
    Rosenberg, Maya C.
    Monge, Jorge
    Parmar, Harsh
    Kaminetzky, David
    Moskovits, Tibor
    Siegel, David S.
    Morgan, Gareth J.
    Niesvizky, Ruben
    Davies, Faith E.
    Biran, Noa
    LEUKEMIA & LYMPHOMA, 2025,
12345